comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 00:41:13 - browse：56771

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Amylyx's ALS drug launch starts strong. It could be trouble for FDA

focus

WSS

Humans aren't the only ones with an imagination. Rats have it too

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Humans aren't the only ones with an imagination. Rats have it too

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Methadone doses haven’t kept up in the age of fentanyl

The best solution to the drug shortages problem

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The best solution to the drug shortages problem

Malaria cases in Florida and Texas: Here’s what you need to know

Explaining an after

Sports medicine is finally prioritizing gender equality

Drastic changes should bring profitability, startup health insurers say

Bright Health sells Medicare Advantage business to Molina

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Bright Health sells Medicare Advantage business to Molina

Police still searching for prisoner who escaped from NYC hospital

focus

All of Us, NIH's precision medicine initiative, gets a big boost

Bill would allow buprenorphine prescription for addiction via telehealth

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Maui's cultural, historic landmarks damaged in the devastating wildfires

FDA panel issues narrow recommendation for Covid vaccine booster doses

Drastic changes should bring profitability, startup health insurers say

Wikipedia

focus

Wikipedia

focus